Delaware Street Capital Master Fund, L.P. is > 10% Shareholder of KEMPHARM, INC. Currently has a direct ownership of 4.1 Million shares of KMPH, which is worth approximately $20.2 Million. The most recent transaction as insider was on Oct 05, 2018, when has been sold 2,000,000 shares (Common Stock, par value $0.0001) at a price of $3.0 per share, resulting in proceeds of $6,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.1M
0% 3M change
0% 12M change
Total Value Held $20.2 Million

Delaware Street Capital Master Fund, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2018
BUY
Open market or private purchase
$6,000,000 $3.0 p/Share
2,000,000 Added 32.81%
4,095,914 Common Stock, par valu...
Jul 30 2018
BUY
Open market or private purchase
$1,217,132 $4.0 p/Share
304,283 Added 12.68%
2,095,914 Common Stock, par valu...
Sep 14 2017
BUY
Open market or private purchase
$458,228 $3.3 p/Share
138,857 Added 7.19%
1,791,631 Common Stock, par valu...
Sep 13 2017
BUY
Open market or private purchase
$607,851 $3.25 p/Share
187,031 Added 10.17%
1,652,774 Common Stock, par valu...
DSC

Delaware Street Capital Master Fund, L.P.

> 10% Shareholder
Chicago, IL

Track Institutional and Insider Activities on KMPH

Follow KEMPHARM, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KMPH shares.

Notify only if

Insider Trading

Get notified when an Kempharm, Inc insider buys or sells KMPH shares.

Notify only if

News

Receive news related to KEMPHARM, INC

Track Activities on KMPH